type your search, and then press enter

News

See what’s new in the field of hereditary eye diseases

Blog managed by the DBGen team, with updated therapies, news and events involving hereditary eye diseases. We invite you to take part in this forum.

Dr. Roser González Duarte has been awarded the SCB Trayectoria Profesional Leandre Cervera 2022

30/06/22 - DBGen,

Dr. Roser Gonzalez Duarte, professor of Genetics, innovative teacher at the Universitat de Barcelona, leader and mentor of many women of science, excellent researcher and disseminator of the genetics underlying inherited retinal dystrophies, counselor of rare disease patients and patient’s associations, enterpreneur and co-founder of DBGen Ocular Genomics, has been awarded the “SCB Trayectoria Profesional Leandre Cervera 2022” by the...

read more

Organoids, generating human eyes for therapy

28/06/22 - Gene editing, Research, Therapy,

  Nowadays, most Hereditary Retinal Diseases lack effective treatment. One of the challenges in the development of new therapies is the difficulty to study the functional and physiological effects of the more than 270 genes that are associated with these pathologies. The second challenge is the generation of a reliable model in which to perform a massive screening of potentially...

read more

DBGen presents and interviews Lluís Montoliu on International Albinism Day

  Today we celebrate International Albinism Day. On this occasion, DBGen interviews Lluís Montoliu, an internationally renowned scientist for his long research career and his relevant contributions to the knowledge of the genetic and molecular basis of albinism. In addition, he is a renowned specialist in gene editing, the generation of animal models of rare diseases, and a highly recognized...

read more

DBGen awarded an EASI-Genomics grant for innovative long-read sequencing of inherited retinal dystrophies

28/06/21 - DBGen, Genetic Diagnosis,

The Transnational Access Committee of the European Advanced infraStructure for Innovative Genomics (EASI-Genomics) has selected the project PID15251 submitted by DBGen Ocular Genomics in the third call for projects of this initiative. DBGen's proposal has successfully passed the scientific and technical evaluation steps of this highly competitive call. EASI-Genomics is an initiative, funded with 10 million euros by the European...

read more

Macular Week: Recent advances in pharmacotherapy for Stargardt disease

25/06/19 - Research, Patients, Stargardt,

Macular Week is all about sensitizing and informing patients, associations, professionals and society of latest achievements on macular degenerative pathologies. In this publication, we will focus on the news on orphan drugs that are currently in the clinical or preclinical phase for the treatment of Stargardt disease. Stargardt disease, the most common inherited macular dystrophy, is characterized by the progressive...

read more

DBGen presented in the PAAO2019 its most relevant results in the genetic diagnosis of eye diseases in Latin American patients

17/06/19 - DBGen, Genetic Diagnosis,

Dr. Roser Gonzàlez Duarte, professor emeritus of genetics at the University of Barcelona and founder of DBGen, attended the XXXIV Pan-American Congress of Ophthalmology held in Cancun (Mexico) from May 25 to 28, 2019. She presented a paper within the session "Clinical and molecular approaches in hereditary ocular pathologies" coordinated by Dr. Cristina Villanueva, an ophthalmologist at the APEC Hospital...

read more
Copyright © 2022. All Rights Reserved -